RNF43 and cancer: In fact, RNF43(3SA) displayed similar oncogenic properties as an established cancer-associated R127P mutation in RNF43, which is within the extracellular protease-associated (PA) domain and abolishes inhibition of Wnt signalling18,29 (Fig. 4a–d, Supplementary Fig. 7c).